Pre‐and post‐HSCT use of TKI therapy for fusion‐driven B‐ALL: A case series of five pediatric, adolescent and young adult patients

MLA

Savannah S. Shumock, et al. “Pre‐and Post‐HSCT Use of TKI Therapy for Fusion‐driven B‐ALL: A Case Series of Five Pediatric, Adolescent and Young Adult Patients.” Cancer Reports, vol. 6, no. 12, Dec. 2023. EBSCOhost, https://doi.org/10.1002/cnr2.1901.

APA

Savannah S. Shumock, William C. Temple, Amanda Marinoff, Kathryn Aaronson, Erica Southworth, Simayijiang Xirenayi, Alex G. Lee, Stanley G. Leung, E. Alejandro Sweet‐Cordero, Michelle Hermiston, Christine Higham, & Elliot Stieglitz. (2023). Pre‐and post‐HSCT use of TKI therapy for fusion‐driven B‐ALL: A case series of five pediatric, adolescent and young adult patients. Cancer Reports, 6(12). https://doi.org/10.1002/cnr2.1901

Chicago

Savannah S. Shumock, William C. Temple, Amanda Marinoff, Kathryn Aaronson, Erica Southworth, Simayijiang Xirenayi, Alex G. Lee, et al. 2023. “Pre‐and Post‐HSCT Use of TKI Therapy for Fusion‐driven B‐ALL: A Case Series of Five Pediatric, Adolescent and Young Adult Patients.” Cancer Reports 6 (12). doi:10.1002/cnr2.1901.